カテゴリ： MarketLine, フランス, 企業調査

LVMH Moet Hennessy Louis Vuitton SA：戦略・SWOT・企業財務分析

◆英語タイトル：LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015134
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：58
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：小売
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

LVMH Moet Hennessy Louis Vuitton SA – Strategy, SWOT and Corporate Finance Report
Summary

LVMH Moet Hennessy Louis Vuitton SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

LVMH Moet Hennessy Louis Vuitton SA (LVMH or ‘the company’) produces and markets luxury goods under various product categories and brands. The company primarily operates in Europe, Asia, and the US. It is headquartered in Paris, France.

Scope

- Detailed information on LVMH Moet Hennessy Louis Vuitton SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting LVMH Moet Hennessy Louis Vuitton SA in the form of a SWOT analysis
- An in-depth view of the business model of LVMH Moet Hennessy Louis Vuitton SA including a breakdown and examination of key business segments
- Intelligence on LVMH Moet Hennessy Louis Vuitton SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about LVMH Moet Hennessy Louis Vuitton SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of LVMH Moet Hennessy Louis Vuitton SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess LVMH Moet Hennessy Louis Vuitton SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on LVMH Moet Hennessy Louis Vuitton SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
LVMH Moet Hennessy Louis Vuitton SA: Company Overview
LVMH Moet Hennessy Louis Vuitton SA: Overview and Key Facts
LVMH Moet Hennessy Louis Vuitton SA: Overview
LVMH Moet Hennessy Louis Vuitton SA: Key Facts
LVMH Moet Hennessy Louis Vuitton SA: Key Employees
LVMH Moet Hennessy Louis Vuitton SA: Key Employee Biographies
LVMH Moet Hennessy Louis Vuitton SA: Major Products and Services
LVMH Moet Hennessy Louis Vuitton SA: Company History
LVMH Moet Hennessy Louis Vuitton SA: Management Statement
LVMH Moet Hennessy Louis Vuitton SA: Locations and Subsidiaries
LVMH Moet Hennessy Louis Vuitton SA: Key Competitors
LVMH Moet Hennessy Louis Vuitton SA: Company Analysis
LVMH Moet Hennessy Louis Vuitton SA: Business Description
LVMH Moet Hennessy Louis Vuitton SA: SWOT Analysis
LVMH Moet Hennessy Louis Vuitton SA: SWOT Overview
LVMH Moet Hennessy Louis Vuitton SA: Strengths
LVMH Moet Hennessy Louis Vuitton SA: Weaknesses
LVMH Moet Hennessy Louis Vuitton SA: Opportunities
LVMH Moet Hennessy Louis Vuitton SA: Threats
LVMH Moet Hennessy Louis Vuitton SA: Corporate Financial Deals Activity
LVMH Moet Hennessy Louis Vuitton SA: Financial Deals Overview
LVMH Moet Hennessy Louis Vuitton SA: Targets and Partners
LVMH Moet Hennessy Louis Vuitton SA: Top Deals 2013 – 2017YTD*
LVMH Moet Hennessy Louis Vuitton SA: Advisors
LVMH Moet Hennessy Louis Vuitton SA: Top Legal Advisors
LVMH Moet Hennessy Louis Vuitton SA: Mergers and Acquisitions
LVMH Moet Hennessy Louis Vuitton SA: Corporate Venturing
LVMH Moet Hennessy Louis Vuitton SA: Partnership
LVMH Moet Hennessy Louis Vuitton SA: Divestments
LVMH Moet Hennessy Louis Vuitton SA: Recent Developments
LVMH Moet Hennessy Louis Vuitton SA: News and Events Summary
LVMH Moet Hennessy Louis Vuitton SA: Business Expansion
LVMH Moet Hennessy Louis Vuitton SA: Corporate Governance
LVMH Moet Hennessy Louis Vuitton SA: Market Developments
LVMH Moet Hennessy Louis Vuitton SA: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: LVMH Moet Hennessy Louis Vuitton SA: Key Facts
Table 2: LVMH Moet Hennessy Louis Vuitton SA: Key Employees
Table 3: LVMH Moet Hennessy Louis Vuitton SA: Locations and Subsidiaries
Table 4: LVMH Moet Hennessy Louis Vuitton SA: Key Competitors
Table 5: LVMH Moet Hennessy Louis Vuitton SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: LVMH Moet Hennessy Louis Vuitton SA: M&A Activity by Geography (TTM*)
Table 7: LVMH Moet Hennessy Louis Vuitton SA: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: LVMH Moet Hennessy Louis Vuitton SA: M&A Average Deal Size - Value (US$m)
Table 9: LVMH Moet Hennessy Louis Vuitton SA: Targets and Partners
Table 10: LVMH Moet Hennessy Louis Vuitton SA: Top Deals 2013 - 2017YTD*
Table 11: LVMH Moet Hennessy Louis Vuitton SA: Legal Advisor Ranking by Value (US$m)
Table 12: LVMH Moet Hennessy Louis Vuitton SA: M&A Volume and Value Trend (2013 - YTD*2017)
Table 13: LVMH Moet Hennessy Louis Vuitton SA: M&A Activity by Geography (2013 - YTD*2017)
Table 14: LVMH Moet Hennessy Louis Vuitton SA: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 15: LVMH Moet Hennessy Louis Vuitton SA: Corporate Venturing by Geography (2013 - YTD*2017)
Table 16: LVMH Moet Hennessy Louis Vuitton SA: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 17: LVMH Moet Hennessy Louis Vuitton SA: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 18: LVMH Moet Hennessy Louis Vuitton SA: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 19: LVMH Moet Hennessy Louis Vuitton SA: Divestments by Geography (2013 - YTD*2017)
Table 20: LVMH Moet Hennessy Louis Vuitton SA: News and Events Summary
Table 21: LVMH Moet Hennessy Louis Vuitton SA: Business Expansion
Table 22: LVMH Moet Hennessy Louis Vuitton SA: Corporate Governance
Table 23: LVMH Moet Hennessy Louis Vuitton SA: Market Developments
Table 24: LVMH Moet Hennessy Louis Vuitton SA: Strategy and Operations

★海外企業調査レポート[LVMH Moet Hennessy Louis Vuitton SA：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Innate Pharma SA (IPH)-製薬・医療分野：企業M&A・提携分析
    Summary Innate Pharma SA (Innate Pharma) is a healthcare products provider that develops immunopharmacology and antibody technology products. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclo …
  • Inflection Biosciences Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Inflection Biosciences Ltd (Inflection Biosciences) is a drug development company focused on discovery and development of small molecule therapeutics for the treatment of cancer. The company’s pipeline products include dual mechanism kinase inhibitors and pim kinase inhibitors including IBL- …
  • Neenah Inc：企業の戦略・SWOT・財務情報
    Neenah Inc - Strategy, SWOT and Corporate Finance Report Summary Neenah Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Alder Biopharmaceuticals Inc (ALDR)：製薬・医療：M&Aディール及び事業提携情報
    Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection sy …
  • Kirby Corporation：戦略・SWOT・企業財務分析
    Kirby Corporation - Strategy, SWOT and Corporate Finance Report Summary Kirby Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Enzo Clinical Labs Inc-医療機器分野：企業M&A・提携分析
    Summary Enzo Clinical Labs Inc (Enzo Clinical), a subsidiary of Enzo Biochem Inc is a medical laboratory that offers testing services. The laboratory develops technologies in the areas of gene regulation and gene modification, biomedical and pharmaceutical research markets. It offers physicians seve …
  • EnviTec Biogas AG (ETG)：企業の財務・戦略的SWOT分析
    EnviTec Biogas AG (ETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Electrical Geodesics Inc：企業の製品パイプライン分析2018
    Summary Electrical Geodesics Inc (EGI) is a medical device company that designs, develops and commercializes non-invasive neuro diagnostic products used to monitor and interpret brain activity. The company offers clinical products such as geodesic EEG system 400 series, spike detection software, geo …
  • Plymouth Tube Company：企業の戦略的SWOT分析
    Plymouth Tube Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • AB Science SA (AB)：製薬・医療：M&Aディール及び事業提携情報
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • Meiji Yasuda Life Insurance Company
    Meiji Yasuda Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Meiji Yasuda Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • RBC Wealth Management：企業の戦略・SWOT・財務情報
    RBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary RBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sahara Petrochemicals Co：企業の戦略的SWOT分析
    Sahara Petrochemicals Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Cyxone AB (CYXO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Cyxone AB (Cyxone) is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases. The company develops T20K, a compound to inhibit pro-inflammatory cytokines, such as IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis after oral ad …
  • Collegium Pharmaceutical Inc (COLL)：企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bespak Europe Ltd：企業の製品パイプライン分析2018
    Summary Bespak Europe Ltd (Bespak), a subsidiary of Consort Medical plc is a medical device company that provides inhalation systems. The company provides products such as inhalation devices, injectables, medical check valves and nasal products. Its inhalation devices comprise dose counting actuator …
  • Lear Corp (LEA)：企業の財務・戦略的SWOT分析
    Lear Corp (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Abiogen Pharma SpA：製薬・医療：M&Aディール及び事業提携情報
    Summary Abiogen Pharma SpA (Abiogen), a subsidiary of MDM Holding SpA, is a specialist pharmaceutical company, which develops, manufactures, and markets medicines with focus on musculo-skeletal health, and rare diseases. The company offers products in the form of oral solids, injectables, semi solid …
  • BioGaia AB (BIOG B)：企業の財務・戦略的SWOT分析
    BioGaia AB (BIOG B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Huatai Securities Co., Ltd. (601688)：企業の財務・戦略的SWOT分析
    Huatai Securities Co., Ltd. (601688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆